Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2021/04/032543
CTRI/2021/04/032543
Not yet recruiting
未知

A prospective, single centre study to investigate volumetric methods for stent expansion by using Optical Coherence Tomographic parameters and its correlation with physiological evaluation and clinical outcomes

PGIMER0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: I208- Other forms of angina pectoris

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: I208- Other forms of angina pectoris
Sponsor
PGIMER
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
PGIMER

Eligibility Criteria

Inclusion Criteria

  • •Patients \>\= 18 and \<\= 75 years of age and undergoing PCI of native coronary arteries for stable ischemic heart disease
  • •At least \>\=1 de novo lesions in a native coronary segment with a visually estimated diameter stenosis between \>\= 50 % and \< 90%, and FFR \<0\.8 will be included
  • •Patient understands and agrees to comply with all specified study requirements and provides written Informed Consent to this effect

Exclusion Criteria

  • •Patients with USA/NSTEMI or ST elevation myocardial infarction
  • •Clinical instability with compromised hemodynamics
  • •Patients with a medical condition that limits the life expectancy to less than one year
  • •Patients scheduled to undergo surgery within 3 months that requires interruption of DAPT
  • •Women who are pregnant or planning to be pregnant
  • •Patients with allergy to contrast agents
  • •Patients with coronary artery bypass graft
  • •Patients with a history of adverse reactions to aspirin, clopidogrel, or prasugrel
  • •Patients in whom optimum OCT image acquisition is not feasible
  • •Patients with chronic renal failure

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
A prospective, Single-Centre study to investigate the plaque characteristics of lesions in young Indian patients of =40 yearsHealth Condition 1: I248- Other forms of acute ischemic heart disease
CTRI/2024/01/061165Dr Nityanand Tripathi
Completed
Not Applicable
A single-center, single-blind study to investigate skin response to sub-therapeutic doses of taspoglutide in GLP-1 analogue naive healthy volunteers
NL-OMON34382Hoffmann-La Roche6
Active, not recruiting
Phase 1
Study to investigate the performance of a newly developed patch insulin pump in patients with type 2 diabetesType 2 diabetes mellitusMedDRA version: 17.1Level: PTClassification code 10053247Term: Insulin-requiring type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersTherapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
EUCTR2014-004078-40-ATCeQur Corp.
Completed
Not Applicable
The effect of dietary rapeseed (canola) versus olive oil supplementation on serum lipids, liver enzymes and postprandial inflammatory responses in adipose tissue in obese men.ObesityNutritional, Metabolic, Endocrine
ISRCTN22073289The Union for the Promotion of Oil and Protein Plants e.V. (Union zur Foerderung von Oel- und Proteinpflanzen e.V) (Germany)20
Completed
Phase 4
TTo evaluate safety and performance of the Evermine 50-50μm Everolimus-Eluting Coronary Stent System (EES) in the treatment of patients with new native coronary artery lesions.Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery
CTRI/2017/09/009939Meril Life Sciences Pvt Ltd171